Multifaceted hyperuricemia: modern approaches to diagnosis from the asymptomatic stage and the choice of treatment strategy
https://doi.org/10.51793/OS.2021.24.6.014
Abstract
On May 24, 2021, within the framework of the IX Eurasian Congress of Cardiology, a symposium «Multifaceted Hyperuricemia»was held online with the assistance of the Egis company. The experts discussed the key points in the diagnosis and treatment of asymptomatic and clinically overt hyperuricemia, as well as the existing discrepancies in foreign and Russian clinical guidelines regarding the level of uric acid in the blood serum, upon reaching which it is necessary to start drug therapy. The questions of the pathogenesis of hyperuricemia, its connection with type 2 diabetes mellitus, arterial hypertension, chronic kidney disease and a number of other diseases were not ignored. The speakers dwelt in detail on the possibilities of normalizing the uric acid indicator through diet and lifestyle modifications (reducing excess body weight, expanding the patient's motor activity) and especially noted that patients who are compliant with therapy achieve great success in the fight against hyperuricemia, which can have a beneficial effect on reducing the risk of developing diseases associated with it, including gout, nephrolithiasis, chronic renal failure, etc.
References
1. Чазова Е. И., Жернакова Ю. В., Кисляк О. А., Недогода С. В. и соавт. Консенсус по ведению пациентов с гипеурикемией и высоким сердечнососудистым риском // Системные гипертензии. 2019; 16 (4): 8-21. https://cyberleninka.ru/article/n/konsensus-po-vedeniyu-patsientov-s-giperurikemieyi-vysokim-serdechno-sosudistym-riskom/viewer. [Chazova Ye. I., Zhernakova Yu. V., Kislyak O. A., Nedogoda S. V. i soavt. Konsensus po vedeniyu patsiyentov s gipeurikemiyey i vysokim serdechnososudistym riskom. [Nedogoda et al. Consensus on the management of patients with hyperuricemia and high cardiovascular risk.] Sistemnyye gipertenzii. 2019; 16 (4): 8-21. https://cyberleninka.ru/article/n/konsensus-po-vedeniyu-patsientov-s-giperurikemiey-i-vysokim-serdechno-sosudistym-riskom/viewer.]
2. Шальнова С. А., Деев А. Д., Артамонова Г. В., Дупляков Д. В. и соавт. Гиперурикемия и ее корреляты в Российской популяции (результаты эпидемиологического исследования ЭССЕ РФ) // Рациональная фармакотерапия в кардиологии. 2014; 10 (2): 153-159. https://www.rpcardio.com/jour/article/view/16?locale=ru_RU. [Shal'nova S. A., Deyev A. D., Artamonova G. V., Duplyakov D. V. i soavt. Giperurikemiya i yeye korrelyaty v Rossiyskoy populyatsii (rezul'taty epidemiologicheskogo issledovaniya ESSE RF). [Hyperuricemia and its correlates in the Russian population (results of an epidemiological study by ESSE RF)] Ratsional'naya farmakoterapiya v kardiologii. 2014; 10 (2): 153-159. https://www.rpcardio.com/jour/article/view/16?locale=ru_RU.]
3. The results of PolSenior Stady // Int J Environ Res Public Health. 2021; 18: 387.
4. Паскарь Н. А. Опыт ведения «Регистра АГ» и проведения клинического аудита медицинской помощи больным артериальной гипертензией // Вестник СПбГУ. 2014; 11 (3): 65-73. https://cyberleninka.ru/article/n/opyt-vedeniya-registra-ag-i-provedeniya-klinicheskogo-audita-meditsinskoypomoschi-bolnym-arterialnoy-gipertenziey. [Paskar' N. A. Opyt vedeniya «Registra AG» i provedeniya klinicheskogo audita meditsinskoy pomoshchi bol'nym arterial'noy gipertenziyey. [Experience in maintaining the "Register of hypertension" and conducting a clinical audit of medical care for patients with arterial hypertension.] Vestnik SPbGU. 2014; 11 (3): 65-73. https://cyberleninka.ru/article/n/opyt-vedeniya-registra-ag-i-provedeniya-klinicheskogo-audita-meditsinskoy-pomoschi-bolnym-arterialnoy-gipertenziey.]
5. The results of NHANES STUDY // Arthritis Rheum. 2011; 63: 345-349.
6. Hyperuricemia and cardiovascular diseases. The Rotterdam Study // Stroke. 2006; 37: 548-569.
7. Lijun Li, Maoxiang Zhao, Chi Wang et al. Early onset of huperuricemia is associated with increased cardiovascular disease and mortality risk // Clinical Research of Cardiology. 2021: 1: 15-24.
8. Чазова И. Е., Жернакова Ю. В от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии // Системные гипертензии. 2019; 16 (1): 6-31. DOI: 10.26442/2075082X.2019.1.190179. [Chazova I. Ye., Zhernakova Yu. V. ot imeni ekspertov. Klinicheskiye rekomendatsii. Diagnostika i lecheniye arterial'noy gipertonii. [Clinical guidelines. Diagnostics and treatment of arterial hypertension.] Sistemnyye gipertenzii 2019; 16 (1): 6-31. DOI: 10.26442/2075082X.2019.1.190179]
9. Grayson P. C., Kim S. Y., LaValley M. et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis // Arthritis Care Res (Hoboken). 2011; 63 (1): 102-110. DOI: 10.1002//acr.20344, indexed in PubMed: 20824805.
10. Kuwabara M., Borghi C., Cicero A. F. G. et al. Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan // Int J Cardiol. 2018; 261: 183-188, indexed in Pubmed: 29551256.
11. Bombelli M., Toso E., Peronio M., Fordi D. The Pamela Study main findings and perspectives // Current Hypertension Reports. 2013; 15 (3): 18-27. https://www.researchgate.net/publication/236266655_The_Pamela_Study_Main_Findings_and_Perspectives.
12. Бадокин В. В. Диагностика и лечение подагрического артрита // Лечащий Врач. 2004; 7: 31-39. https://www.lvrach.ru/2004/07/4531505. [Badokin V. V. Diagnostika i lecheniye podagricheskogo artrita. [Diagnosis and treatment of gouty arthritis.] The Lechaschi Vrach Journal. 2004; 7: 31-9. https://www.lvrach.ru/2004/07/4531505.]
13. Maloberti A., Bombelli M., Rita Facchetti et al. Relationships between diureticrelated hyperuricemia and cardiovascular events: data from the Uric acid Right for heArt Health study // J. Hypertension. 2021; 2 (39): 156-163.
14. Farquharson C. A. et al. Allopurinol improves endothelial dysfunction in chronic heart failure // Circulation. 2002; 106 (2): 221-226.
15. White W. B., Saag K. G., Becker M. A. et al. Cardiovascular safety of Febuxostat or Allopurinol in patiens with gout // New England J. Med. 2018; 11 (1): 22-26.
16. Barrientos-Regala M., Pestano N. S., Punzalan F. E. R. et al. The association of Febuxostat compared with Allopurinol on blood pressure and major adverse cardiac events among adult patients with hyperuricemia: a meta-analysis // J. Cardiovasc Pharmacolog. 2020; 76 (4): 461-471. https://pubmed.ncbi.nlm.nih.gov/32675751/.
17. Yang W. X., Ma Y., Hau Y. L., Wang Y. B. et al // Clin Lab. 2019; 65 (8): 10.7754.
18. Chen-Xu M., Yakose C., Rai S. K. et al. // Arthritis Reumatol. 2019; 71: 991-999.
19. Shimazaki S., Kazukawa I., Mori K., Kihara M., Minagawa M. Acute kidney injury caused by ammonium acid urate crystals in diabetic ketoacidosis at the onset of type 1 diabetes mellitus // Endocrinol Diabetes Metab Case Rep. 2021 Feb 26; 2021: EDM200143. DOI: 10.1530/EDM-20-0143. Online.
20. Fagundes A. C., de Oliveira E. D., Ferrari S. G. et al. Allopurinol for fibromialgia pain in adults: a randomized controlled trial // Pain Pract. 2021; Apr. 17. DOI: 10.1111/papr.13019/ Online ahead of print.
21. Hu Y., Chan Z., Li C. et al. Higher serum uric acid levels are associated with an increased risk of vision-threatening diabetic retinopathy in type 2 diabetes patients // Invest Ophtalmol Vis Sci. 2021; Apr. 1; 62 (4): 23. DOI: 10.1167/iovs.62.4.23.
22. E79.0 Гиперурикемия без признаков воспалительного артрита и подагрических узлов // Электронная энциклопедия лекарств РЛС: https://www.rlsnet.ru/mkb_index_id_2325.htm. [E79.0 Giperurikemiya bez priznakov vospalitel'nogo artrita i podagricheskikh uzlov. [E79.0 Hyperuricemia without signs of inflammatory arthritis and gouty nodes.] Elektronnaya entsiklopediya lekarstv RLS https://www.rlsnet.ru/mkb_index_id_2325.htm.]
23. Genome-wide association studies (GWAS): https://www.ebi.ac.uk/gwas/home.
24. Tin F. et al. Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels // Nat Genet. 2019: 51, 1459-1474. https://www.nature.com/articles/s41588-019-0504-x.
Review
For citations:
Kovaleva I.V. Multifaceted hyperuricemia: modern approaches to diagnosis from the asymptomatic stage and the choice of treatment strategy. Lechaschi Vrach. 2021;(6):64-71. (In Russ.) https://doi.org/10.51793/OS.2021.24.6.014
Views:
320
JATS XML
Email this article 
